Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
- 1 July 1998
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 11 (3) , 450-479
- https://doi.org/10.1128/cmr.11.3.450
Abstract
SUMMARY: Since their initial recognition 20 years ago, Shiga toxin-producing Escherichia coli (STEC) strains have emerged as an important cause of serious human gastrointestinal disease, which may result in life-threatening complications such as hemolytic-uremic syndrome. Food-borne outbreaks of STEC disease appear to be increasing and, when mass-produced and mass-distributed foods are concerned, can involve large numbers of people. Development of therapeutic and preventative strategies to combat STEC disease requires a thorough understanding of the mechanisms by which STEC organisms colonize the human intestinal tract and cause local and systemic pathological changes. While our knowledge remains incomplete, recent studies have improved our understanding of these processes, particularly the complex interaction between Shiga toxins and host cells, which is central to the pathogenesis of STEC disease. In addition, several putative accessory virulence factors have been identified and partly characterized. The capacity to limit the scale and severity of STEC disease is also dependent upon rapid and sensitive diagnostic procedures for analysis of human samples and suspect vehicles. The increased application of advanced molecular technologies in clinical laboratories has significantly improved our capacity to diagnose STEC infection early in the course of disease and to detect low levels of environmental contamination. This, in turn, has created a potential window of opportunity for future therapeutic intervention.Keywords
This publication has 368 references indexed in Scilit:
- An outbreak due to enterohaemorrhagic Escherichia coli O157: H7 in a children day care centre characterized by person-to-person transmission and environmental contaminationZentralblatt für Bakteriologie, 1994
- Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritisThe Journal of Pediatrics, 1992
- Cloning and Sequencing of a Shiga-like Toxin II-Related Gene from Escherichia coli O157: H7 Strain 7279Zentralblatt für Bakteriologie, 1992
- High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndromeThe Journal of Pediatrics, 1991
- Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndromeThe Journal of Pediatrics, 1990
- Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observationsThe Journal of Pediatrics, 1990
- The primary structure of the operons coding for Shigella dysenteriae toxin and temperate phage H30 shiga-like toxinGene, 1988
- Globotriosyl ceramide is specifically recognized by the escherichia coli verocytotoxin 2Biochemical and Biophysical Research Communications, 1988
- A Severe Outbreak ofEscherichia coliO157:H7–Associated Hemorrhagic Colitis in a Nursing HomeNew England Journal of Medicine, 1987
- Hemorrhagic Colitis Associated with a RareEscherichia coliSerotypeNew England Journal of Medicine, 1983